2018 American Transplant Congress Archives - Page 176 of 211

Successful Patency in Blood Conduits for an Artificial Kidney Membrane with Biocompatible Coatings

R. Forbes,¹ E. Marsh,¹ S. Karp,¹ A. Buck,¹ D. Colvin,¹ P. Williams,¹ B. Chaudhuri,² S. Roy,² W. Fissell.¹
Successful Transplantation in a Sensitized Patient Allergic to Commercially Available Antibody Induction Agents

K. Venkatachalam, A. Malone.
Successful Transplantation of Black Kidneys from Rhabdomyolysis Donors

X-.P. Yuan,¹ C-.B. CHen,¹ Y. Zheng,¹ X. Gu,² Q. Zu,³ C. Wang,¹ X. He.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85 in Older Recipients

A. Nickkholgh,¹ A. Agarwal,¹ A. Nishio Lucar,² K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85: The Organ is Not Wholly to Blame

A. Agarwal,¹ A. Nishio Lucar,² A. Nickkholgh,¹ K. Brayman,¹ A. Doyle,² J. Oberholzer.¹
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis

L. Coromina Hernandez, K. Sasaki, D. Firl, J. McVey, M. Fujiki, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
Supercooling of Human Livers to Extend the Preservation Time for Transplantation

R. de Vries,^1,2 S. Tessier,^1,2 P. Banik,^1,2 S. Ozer,^1,2 S. Napgal,^1,2 S. Cronin,^1,2 J. Markmann,^1,2 H. Yeh,^1,2 K. Uygun.^1,2
Superior Outcomes Using Normothermic Regional Perfusion in CDCD Liver Transplantation

A. Hessheimer, E. Coll, A. Valdivieso, M. Gómez, J. Santoyo, P. Ramírez, M. Gómez-Bravo, R. López-Andujar, J. Villar, C. Jiménez, F. Lluís, L. Lladó, D. Casanova, M. Barrera, R. Charco, J. López-Baena, J. Briceño, F. Pardo, G. Blanco, D. Pacheco, B. Domínguez-Gil, V. Sánchez-Turrión, C. Fondevila.
Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

M. J. Barten,¹ S. W. Hirt,¹ J. Garbade,¹ C. Bara,¹ A. Doesch,¹ C. Knosalla,¹ C. Grinninger,¹ J. Stypmann,¹ C. Sieder,² M. Junge,² U. Schulz.¹
Superiority of Early Everolimus-Based Quadruple Immunosuppression versus Standard Triple Therapy after Lung Transplantation: 12 Months Results from Prospective 4EVERLUNG Study in Germany

J. Gottlieb, C. Neurohr, J. Müller-Quernheim, H. Wirtz, B. Sill, H. Wilkens, V. Besa, C. Knosalla, M. Junge, C. Capusan, M. Strüber.